大肠埃希菌和屎肠球菌致腹膜透析前腹膜炎一例
A Case of Escherichia coli and Enterococcus faecium-Associated Peritonitis before Peritoneal Dialysis
摘要: 腹膜透析相关性腹膜炎是腹膜透析技术失败的主要原因之一,其中大肠埃希菌和屎肠球菌所致腹膜炎病情更严重,预后更差,通常导致较高的治疗失败率。本例女性患者基础病为IgA肾病,因肌酐升高,外院中医中药治疗3周后渐出现全身皮疹、颜面部及双下肢水肿、发热十余天。入我院后给予腹膜透析置管,术中引流腹腔积液呈深黄色浑浊液体,腹水及尿培养示大肠埃希菌和屎肠球菌。根据检查化验、培养结果,先后调整抗生素万古霉素、美罗培南等静脉及腹腔用药,给予透析、运动、营养、心理、皮肤护理、健康宣教等综合精细积极对症支持治疗、护理后,患者皮疹消褪、体温正常、腹水常规正常。
Abstract: Peritoneal dialysis related peritonitis is one of the main reasons for the failure of peritoneal dialysis technology. The peritonitis caused by Escherichia coli and Enterococcus faecium is more serious and the prognosis is worse, which usually leads to a higher treatment failure rate. The basic disease of this female patient is IgA nephropathy. Due to the elevated creatinine, after 3 weeks of treatment with traditional Chinese medicine in another hospital, she gradually developed systemic rash, facial and lower limb edema, and fever for more than 10 days. After entering our hospital, peritoneal di-alysis was given and catheters were placed. During the operation, peritoneal effusion was drained as dark yellow turbid liquid. Ascites and urine culture showed Escherichia coli and Enterococcus faecium. According to the test and culture results, the intravenous and intraperitoneal drugs such as vancomycin and meropenem were adjusted successively, and the patients’ skin rash subsided, their body temperature was normal, and their ascites were normal after giving comprehensive and fine symptomatic support treatment and care such as dialysis, exercise, nutrition, psychology, skin care, health education.
文章引用:卢冬梅, 杨秀玲, 陈丽丽, 李楠, 赵春蕾, 于雪晴. 大肠埃希菌和屎肠球菌致腹膜透析前腹膜炎一例[J]. 临床医学进展, 2022, 12(8): 7244-7248. https://doi.org/10.12677/ACM.2022.1281046

参考文献

[1] Ma, T.K., Chow, K.M., Kwan, B.C., et al. (2016) Peritonitis before Peritoneal Dialysis Training: Analysis of Causative Organisms, Clinical Outcomes, Risk Factors, and Long-Term Consequences. Clinical Journal of the American Society of Nephrology, 11, 1219-1226. [Google Scholar] [CrossRef
[2] Li, Y.F., Su, N., Chen, S.Y., et al. (2016) Genetic Background of Escherichia coli Isolates from Peritoneal Dialysis Patients with Peritonitis and Uninfected Control Subjects. Genetics and Molecular Research, 15, No. 1. [Google Scholar] [CrossRef] [PubMed]
[3] Feng, X., Yang, X., Yi, C., et al. (2014) Escherichia coli Peritonitis in Peritoneal Dialysis: The Prevalence, Antibiotic Resistance and Clinical Outcomes in a South China Dialysis Center. Peri-toneal Dialysis International, 34f, 308-316. [Google Scholar] [CrossRef] [PubMed]
[4] 吕媛, 李耘, 薛峰, 张秀珍,胡云建, 于庭, 胡志东, 赵建宏, 潘世扬, 胡必杰, 俞云松, 邓秋连, 李艳, 刘文恩, 周玲, 费樱, 府伟, 徐修礼, 裴凤艳, 孟灵, 季萍, 汤进, 欧尾妹. 卫生部全国细菌耐药监测网(Mohnarin) 2011-2012年度血流感染细菌耐药监测报告[J]. 中国临床药理学杂志, 2014, 30(3): 278-288. [Google Scholar] [CrossRef
[5] Edey, M., Hawley, C.M., McDonald, S.P., et al. (2010) Enterococcal Peritonitis in Australian Peritoneal Dialysis Patients: Predictors, Treatment and Outcomes in 116 Cases. Nephrology Dialysis Transplantation, 25, 1272-1278. [Google Scholar] [CrossRef] [PubMed]
[6] 韦丽芳, 韦梅娟, 赖珍琼, 韦俏如, 王洁. 微信平台健康教育模式对中青年居家腹膜透析患者焦虑及抑郁的干预效果[J]. 右江医学, 2019, 47(12): 912-915.
[7] 中国医师协会肾脏内科医师分会, 中国中西医结合学会肾脏疾病专业委员会营养治疗指南专家协作组. 中国慢性肾脏病营养治疗临床实践指南(2021版) [J]. 中华医学杂志, 2021, 101(8): 539-559.
[8] 徐玉林, 张春秀. 腹膜透析病人运动干预研究进展[J]. 护理研究, 2020, 34(24): 4429-4432.
[9] 孟秀娟, 吴安华. 如何应对多重耐药菌医院感染的严峻挑战[J]. 中国感染控制杂志, 2019, 18(3): 185-192.
[10] Li, P.K., et al. (2022) ISPD Peritonitis Guideline Recommenda-tion: 2022 Update on Prevention and Treatment. Peritoneal Dialysis International, 42, 110-153. [Google Scholar] [CrossRef] [PubMed]
[11] Gudiol, C., Ayats, J., Camoez, M., et al. (2013) Increase in Bloodstream Infection due to Vancomycin-Susceptible Enterococcus faecium in Cancer Patients: Risk Factors, Molecular Epidemiology and Outcomes. PLOS ONE, 8, e74734. [Google Scholar] [CrossRef] [PubMed]